Editor's Column

John C. Deutsch, M.D.

 

Mechanical Therapy for GERD

Figure 1A


Heartburn and gastroesophageal reflux are common problems in clinical practice. Significant advances have been made in the diagnosis and pharmacologic management of these conditions over the past 25 years. The etiology of GERD is multifactorial, although transient lower esophageal sphincter relaxations are thought to play an important role in addition to poor esophageal clearance and weak lower esophageal sphincter pressures (1,2). For many subjects with these complaints, simple measures such as changes in eating, or weight loss, can provide a significant benefit. Patients often have symptoms despite these measures, or are unable to comply with these recommendations and end up on medications. For those with severe reflux, particularly erosive esophagitis, the proton pump inhibitor medications seem to be the most efficacious treatment (3-5).

In some patients, breakthrough symptoms appear to occur. Medical therapy for these patients can be complicated and expensive, and the best approach to these patients is debated (5,6). Some patients are reluctant to be on life long medical therapy. Patients with regurgitation and aspiration can also be difficult to manage medically. Surgery has played a role in the management of these patients for many years, and the results appear to be efficacious. However, patient selection appears to be important (7,8).

This issue of the Visible Human Journal of Endoscopy (VHJOE) presents the following expert reviews: "Laparoscopic Antireflux Surgery" b. Drs. Kellogg, Oelschlager, and Pellegrini and "Endoscopic Antireflux" by Dr. Gostout for an update on therapies that can be considered in those patients in whom a mechanical approach seems warranted. These mechanical therapies are directed towards the gastroesophageal junction. As seen in Figures 1A and IB from Visible Human data, the diaphragm and intrinsic esophageal musculature appear to be important. For those who wish to examine the anatomy of this region in more detail, please click on the link below Figure 1A to view the Interactive Atlas image.

Regarding updates to the VHJOE, we soon hope to provide a drop down menu to allow one to link to all of our previously published expert review articles. We hope this makes it easier for readers to enjoy VHJOE. I also want to take this time to personally thank Dr. Peter McNally for selecting the topics and authors for our Expert Review section of VHJOE. I also want to thank Julie Giron for her excellent work in laying out the current format of the journal.


References

1. Katz PO. Optimizing medical therapy for gastroesophageal reflux disease: state of the art. Rev Gastroenterol Disord. 2003 Spring;3(2):59-69.

2. Arora AS, Castell DO. Medical therapy for gastroesophageal reflux disease. Mayo Clin Proc. 2001 Jan;76(1):102-6.

3. Berardi RR. A critical evaluation of proton pump inhibitors in the treatment of gastroesophageal reflux disease. Am J Manag Care. 2000 May;6(9 Suppl):S491-505.

4. DiPalma JA. Management of severe gastroesophageal reflux disease. J Clin Gastroenterol. 2001 Jan;32(1):19-26.

5. Ramakrishnan A, Katz PO. Pharmacologic management of gastroesophageal reflux disease. Curr Gastroenterol Rep. 2002 Jun;4(3):218-24.

6. Cross LB, Justice LN. Combination drug therapy for gastroesophageal reflux disease. Ann Pharmacother. 2002 May;36(5):912-6.

7. Allgood PC, Bachmann M. Medical or surgical treatment for chronic gastrooesophageal reflux? A systematic review of published evidence of effectiveness. Eur J Surg. 2000 Sep;166(9):713-21.

8. Kahrilas PJ. Management of GERD: medical versus surgical. Semin Gastrointest Dis. 2001 Jan;12(1):3-15.

 




Editorial Board:
Manoop S. Bhutani, M.D.
Galveston, TX
William R. Brugge, M.D.
Boston, MA
Peter R. McNally, D.O.
Denver, CO
Iqbal S. Sandhu, M.D.
Salt Lake City, UT
Thomas J. Savides, M.D.
San Diego, CA

Copyright © 2003, University of Colorado, All Rights Reserved
Privacy Policy